References
- Bogani G, Dowdy SC, Cliby WA, Ghezzi F, Rossetti D, Mariani A. Role of pelvic and para-aortic lymphadenectomy in endometrial cancer: current evidence. J Obstet Gynaecol Res. 2014;40(2):301–311. doi:https://doi.org/10.1111/jog.12344.
- Rossi PJ, Horowitz IR, Johnstone PA, Jani AB. Lymphadenectomy for patients with cervical cancer: is it of value? J Surg Oncol. 2009;100(5):404–406. doi:https://doi.org/10.1002/jso.21330.
- Bogani G, Dowdy SC, Cliby WA, et al. Management of endometrial cancer: issues and controversies. Eur J Gynaecol Oncol. 2016;37(1):6–12.
- Hareyama H, Hada K, Goto K, et al. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study. Int J Gynecol Cancer. 2015;25(4):751–757. doi:https://doi.org/10.1097/IGC.0000000000000405.
- Lindqvist E, Wedin M, Fredrikson M, Kjolhede P. Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2017;211:112–121. doi:https://doi.org/10.1016/j.ejogrb.2017.02.021.
- Bona AF, Ferreira KR, Carvalho RBM, Thuler LCS, Bergmann A. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697–1704. doi:https://doi.org/10.1136/ijgc-2020-001682.
- Abu-Rustum NR, Alektiar K, Iasonos A, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol. 2006;103(2):714–718. doi:https://doi.org/10.1016/j.ygyno.2006.03.055.
- Bae HS, Lim MC, Lee JS, et al. Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer. Ann Surg Oncol. 2016;23(1):186–195. doi:https://doi.org/10.1245/s10434-015-4613-1.
- Todo Y, Yamamoto R, Minobe S, et al. Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol. 2010;119(1):60–64. doi:https://doi.org/10.1016/j.ygyno.2010.06.018.
- Hsu MC, Itkin M. Lymphatic anatomy. Tech Vasc Interv Radiol. 2016;19(4):247–254. doi:https://doi.org/10.1053/j.tvir.2016.10.003.
- Cambria RA, Gloviczki P, Naessens JM, Wahner HW. Noninvasive evaluation of the lymphatic system with lymphoscintigraphy: a prospective, semiquantitative analysis in 386 extremities. J Vasc Surg. 1993;18(5):773–782. doi:https://doi.org/10.1016/0741-5214(93)90331-F.
- Barlin JN, Khoury-Collado F, Kim CH, et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol. 2012;125(3):531–535. doi:https://doi.org/10.1016/j.ygyno.2012.02.021.
- Cho KH, Han EY, Lee SA, Park H, Lee C, Im SH. Feasibility of bioimpedance analysis to assess the outcome of complex decongestive therapy in cancer treatment-related lymphedema. Front Oncol. 2020;10:111.
- International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology. 2013;46:1–11.
- Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Lower body lymphedema in patients with gynecologic cancer. Anticancer Res. 2017;37(8):4005–4015.
- Kim JH, Choi JH, Ki EY, et al. Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer. Int J Gynecol Cancer. 2012;22(4):686–691. doi:https://doi.org/10.1097/IGC.0b013e3182466950.
- Hayes SC, Janda M, Ward LC, et al. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol. 2017;146(3):623–629. doi:https://doi.org/10.1016/j.ygyno.2017.06.004.
- Carlson JW, Kauderer J, Hutson A, et al. GOG 244-The lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients. Gynecol Oncol. 2020;156(2):467–474. doi:https://doi.org/10.1016/j.ygyno.2019.10.009.
- McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. JCO. 2008;26(32):5213–5219. doi:https://doi.org/10.1200/JCO.2008.16.3725.
- Novackova M, Halaska MJ, Robova H, et al. A prospective study in detection of lower-limb lymphedema and evaluation of quality of life after vulvar cancer surgery. Int J Gynecol Cancer. 2012;22(6):1081–1088. doi:https://doi.org/10.1097/IGC.0b013e31825866d0.
- Leitao MM, Jr., Zhou QC, Gomez-Hidalgo NR, et al. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecol Oncol. 2020;156(1):147–153. doi:https://doi.org/10.1016/j.ygyno.2019.11.003.
- He L, Qu H, Wu Q, Song Y. Lymphedema in survivors of breast cancer. Oncol Lett. 2020;19:2085–2096.
- Rebegea LF, Stoleriu G, Manolache N, et al. Associated risk factors of lower limb lymphedema after treatment of cervical and endometrial cancer. Exp Ther Med. 2020;20(6):1–1. doi:https://doi.org/10.3892/etm.2020.9311.
- Papadia A, Imboden S, Gasparri ML, Siegenthaler F, Fink A, Mueller MD. Endometrial and cervical cancer patients with multiple sentinel lymph nodes at laparoscopic ICG mapping: How many are enough? J Cancer Res Clin Oncol. 2016;142(8):1831–1836. doi:https://doi.org/10.1007/s00432-016-2193-5.
- Suzuki M, Ohwada M, Sato I. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial "no-closure" for ovarian and endometrial cancers. J Surg Oncol. 1998;68(3):149–152. doi:https://doi.org/10.1002/(SICI)1096-9098(199807)68:3<149::AID-JSO3>3.0.CO;2-5.
- Ghezzi F, Uccella S, Cromi A, et al. Lymphoceles, lymphorrhea, and lymphedema after laparoscopic and open endometrial cancer staging. Ann Surg Oncol. 2012;19(1):259–267. doi:https://doi.org/10.1245/s10434-011-1854-5.